Skip Ribbon Commands
Skip to main content

​COVID-19 Vaccine

As of September 1, the CDC is recommending a new COVID-19 booster that is expected to give better protection against the BA.4 and BA.5 subvariants of the Omicron variant. The new "bivalent" formulation of the Pfizer vaccine is recommended as a booster for individuals ages 12 and older, and the new "bivalent" formulation of the Moderna vaccine is recommended as a booster for individuals ages 18 and older. Read the September 1 news release from the CDC for more information.

Bivalent booter doses are now available in Mecklenburg County. Make an appointment online for an MCPH clinic or visit your local pharmacy to get your booster and flu shot. MCPH clinic locations and hours are listed below.
get the facts and get vaccinated


COVID-19 Vaccine Recommendations

The US Centers for Disease Control and Prevention (CDC) recommends the Pfizer and Moderna COVID-19 vaccines for everyone aged 6 months and older, including pregnant women and people with compromised immune systems. And as of July 19, the CDC also recommends the new two-dose Novavax COVID-19 Vaccine, Adjuvanted, for adults ages 18 and older.

As of September 1, the CDC recommends the new bivalent formualtions of the Pfizer and Moderna vaccines as boosters, following the US Food and Drug Administration's (FDA's) revision of the emergency use authorizations (EUAs) of the Moderna and Pfizer vaccine on August 31:

  • The new Pfizer and Moderna vaccines’ bivalent formulas (which contain mRNA parts of the Omicron BA.4 and BA.5 subvariants in addition to mRNA parts from the original strain of the coronavirus) given as a single booster dose at least 2 months after the last dose of the primary vaccine series or booster dose for individuals ages 12 and older for Pfizer and individuals 18 and older for Moderna.
  • The original Pfizer and Moderna vaccines’ monovalent formulas (which contain mRNA parts of only the original strain of the coronavirus) are no longer given as booster doses for individuals 12 years of age and older. The original Pfizer and Moderna vaccines will continue to be given as the primary series vaccines for individuals ages 6 months and older and as booster doses for individuals 5 through 11 years of age at least 5 months after the last dose of the primary series.

See the COVID-19 Vaccine Schedule for Most People table and COVID-19 Vaccine Schedule for People Who are Immunocompromised table below to see recommended vaccine types and appropriate dosing schedule for most people, including children, and for people with compromised immune systems.


Find the COVID-19 Vaccine Near You

  • The map below shows the locations of providers offering COVID-19 vaccines, testing, and treatment in Mecklenburg County.

  • Both MCPH clinic locations offer the Pfizer and Moderna COVID-19 vaccines; we are currently waiting on shipments of the Novavax vaccine. Walk in during the hours listed below or make an appointment online or by calling 980-314-9400:

Northwest Health Department2845 Beatties Ford Road
Mon, Tues, Thurs, Fri: 8:30 am - 11:30 am; 1:00 pm - 4:30 pm
Wed: 10:30 am - 1:30 pm; 3:00 pm - 6:30 pm

Southeast Health Department249 Billingsley Road
Mon, Tues, Thurs, Fri: 8:30 am - 11:30 am; 1:00 pm - 4:30 pm
Wed: 10:30 am - 1:30 pm; 3:00 pm - 6:30 pm

 

map menu button   Press the map menu button to view the map key and additional functionality.
   Open map in new window

COVID-19 Vaccine Information

The primary series of the vaccine, followed by booster doses, protects against severe COVID-19 illness, hospitalization, and death by triggering your body to make antibodies against the SARS-CoV-2 virus that causes COVID-19 illness. Vaccine immunity is long lasting and safe. SARS-CoV-2 infection also triggers your body to make antibodies against re-infection, but that natural immunity is temporary (about 90 days) and comes with the risk of severe illness, hospitalization, and death.

Visit the links below for information about the COVID-19 vaccines:


COVID-19 Vaccination Schedule for Most People
Manufacturer Age Group Dose 1 Dose 2 Dose 3
Pfizer-BioNTech / COMIRNATY

(mRNA vaccine type)
6 months - 4 years Initial dose
(primary series)
3 - 8 weeks after Dose 1
(primary series)
At least 8 weeks after Dose 2
(primary series)
5 - 11 years Initial dose
(primary series)
3 - 8 weeks after Dose 1
(primary series)
At least 5 months after Dose 2
(monovalent booster)
12+ years Initial dose
(primary series)
3 - 8 weeks after Dose 1
(primary series)
At least 2 months after Dose 2
(bivalent booster)
Moderna / Spikevax

(mRNA vaccine type)
6 months - 4 years Initial dose
(primary series)
4 - 8 weeks after Dose 1
(primary series)
5 - 17 years Initial dose
(primary series)
4 - 8 weeks after Dose 1
(primary series)
18+ years Initial dose
(primary series)
4 - 8 weeks after Dose 1
(primary series)
At least 2 months after Dose 2
(bivalent booster)
Novavax COVID-19 Vaccine, Adjuvanted

(protein subunit vaccine type)
12+ years Initial dose
(primary series)
3 - 8 weeks after Dose 1
(primary series)
At least 2 months after Dose 2
(bivalent booster)
Janssen / Johnson & Johnson*

(viral vector vaccine type)
18+ years Initial dose
(primary series)
At least 2 months after Dose 1
(bivalent booster)
* Age-appropriate Pfizer or Moderna COVID-19 vaccines are preferred over the Janssen COVID-19 vaccine for primary and booster vaccination. Janssen COVID-19 vaccine should only be used in limited situations.

COVID-19 Vaccination Schedule for People Who are Immunocompromised
Manufacturer Age Group Dose 1 Dose 2 Dose 3 Dose 4
Pfizer-BioNTech / COMIRNATY

(mRNA vaccine type)
6 months - 4 years Initial dose
(primary series)
3 weeks after Dose 1
(primary series)
At least 8 weeks after Dose 2
(primary series)
5 - 11 years Initial dose
(primary series)
3 weeks after Dose 1
(primary series)
At least 4 weeks after Dose 2
(primary series)
At least 3 months after Dose 3
(monovalent booster)
12+ years Initial dose
(primary series)
3 - 8 weeks after Dose 1
(primary series)
At least 4 weeks after Dose 2
(primary series)
At least 2 months after Dose 3
(bivalent booster)
Moderna / Spikevax

(mRNA vaccine type)
6 months - 4 years Initial dose
(primary series)
4 weeks after Dose 1
(primary series)
At least 4 weeks after Dose 2
(primary series)
5 - 17 years Initial dose
(primary series)
4 weeks after Dose 1
(primary series)
At least 4 weeks after Dose 2
(primary series)
18+ years Initial dose
(primary series)
4 weeks after Dose 1
(primary series)
At least 4 weeks after Dose 2
(primary series)
At least 2 months after Dose 3
(bivalent booster)
Novavax COVID-19 Vaccine, Adjuvanted

(protein subunit vaccine type)
12+ years Initial dose
(primary series)
3 weeks after Dose 1
(primary series)
At least 2 months after Dose 2
(bivalent booster)
Janssen / Johnson & Johnson*

(viral vector vaccine type)
18+ years Initial dose
(primary series)
At least 4 weeks after Dose 1
(additional Pfizer or Moderna dose)
At least 2 months after Dose 2
(bivalent booster)
* Age-appropriate Pfizer or Moderna COVID-19 vaccines are preferred over the Janssen COVID-19 vaccine for primary and booster vaccination. Janssen COVID-19 vaccine should only be used in limited situations.

WE'RE HERE TO ANSWER YOUR QUESTIONS

Public Health Hotline: 980-314-9400

Option 3 (English) or Opción 8 (Español)

Monday-Friday, 8 a.m. - 5 p.m.

This hotline is for general questions regarding COVID-19 and vaccines.
If you have a medical emergency, call 911.